摘要
目的:研究痛泻要方加马来酸曲美布汀协同治疗腹泻型肠易激综合征的疗效。方法:将40例肠易激综合征患者随机分为治疗组20例和对照组20例。治疗组采用痛泻要方联合马来酸曲美布汀治疗;对照组仅采用马来酸曲美布汀治疗,疗程均为4周。结果:治疗组总有效率是90%,对照组总有效率是70%。治疗组总有效率显著优于对照组(P<0.05),差异具有统计学意义。结论:痛泻要方协同马来酸曲美布汀治疗腹泻型肠易激综合征的疗效显著。
Objective To investigate efficacy of the Tongxie prescription plus Trimebutine maleate on irritable bowel syndrome ofdiarrhea type. Methods： 40 patients were randomly divided into the treatment group and the control group, 20 cases for each. The treatmentgroup was given the Tongxie prescription plus Trimebutine maleate; and the control group was treated with Trimebutine maleate simply, 4weeks as a course. Results： The total efficiency is 90% in the treatment group, better than 70% in the control group （P〈0.05）. Conclusion：The Tongxie prescription plus Trimebutine maleate on irritable bowel syndrome of diarrhea type shows a significant effect.
出处
《中医临床研究》
2016年第7期94-94,96,共2页
Clinical Journal Of Chinese Medicine
关键词
痛泻药方
马来酸曲美布汀
肠易激综合征
The Tongxie prescription
Trimebutine maleate
Irritable bowel syndrome
